Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

150.61 +0.70 (+0.47%)
Streaming Delayed Price Updated: 1:20 PM EDT, May 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,121,710
Open 150.04
Bid (Size) 150.60 (2)
Ask (Size) 150.62 (3)
Prev. Close 149.91
Today's Range 149.71 - 150.94
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.16%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
Kenvue stock is up on Monday after Johnson & Johnson announced plans to sell its entire stake in KVUE following last year's spinoff. 
Via InvestorPlace
2 Supercharged Dividend Stocks to Buy and Hold for Years
Consistent passive income is one top goal long-term investors should have for their portfolio. 
Via The Motley Fool

Performance

YTD
-5.85%
-5.85%
1 Month
+2.09%
+2.09%
3 Month
-4.59%
-4.59%
6 Month
+2.02%
+2.02%
1 Year
-5.60%
-5.60%

More News

Read More
The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024
Via InvestorPlace
7 Reliable Dividend Stocks to Keep Your Portfolio Upright
Via InvestorPlace
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Via The Motley Fool
1 Passive Income Vehicle Every Investor Should Own
Via The Motley Fool
The 3 Best Mutual Funds to Buy in May 2024
Via InvestorPlace
The 3 Most Undervalued Stocks to Buy in May 2024
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
Via The Motley Fool
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
Via FinancialNewsMedia
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
Via InvestorPlace
What Is the Dividend Payout for Johnson & Johnson Stock?
Via The Motley Fool
The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024
Via InvestorPlace
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy
Via Benzinga
Shockwave Medical Reports First Quarter 2024 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Via Benzinga
Steady Dividend Plays: 3 Aristocrat Stocks to Own Now
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical,
From Brodsky & Smith LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.